Amphix Bio

Raised $12.5M in a Seed round, announced 18 December 2025.

Round

Initial close of a $12.5M seed round (investors not named, existing investors followed on) to move lead candidates toward human clinical trials.

Amount
$12.5M
Stage
Seed
Announced
18 December 2025
Use of funds
Initial close of a $12.5M seed round (investors not named, existing investors followed on) to move lead candidates toward human clinical trials.
Checked
Amount and date matched across 2 press sources

Company

Regenerative peptide nanostructure therapies for neurological and musculoskeletal conditions

Based in
Chicago, United States
Sector
AI
Website
amphixbio.com ↗

Sources and links

Sources
Amphix Bio raises $12.5M seed round to advance peptide drug platform - PR Newswire pulse2.com
Amphix Bio raises $12.5M seed round to advance peptide drug platform - PR Newswire news.google.com
Website
amphixbio.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost